Emler S, Praplan P, Rohner P, Auckenthaler R, Hirschel B
Division des maladies infectieuses, Hôpitaux universitaires de Genève.
Schweiz Med Wochenschr. 1996 Jun 15;126(24):1062-5.
A 29-year-old patient with AIDS was hospitalized with weight loss, fever and cough. Mycobacterial cultures from sputum, blood and bronchoalveolar lavage became positive after 3 weeks' incubation. When using a DNA probe for identification of Mycobacterium tuberculosis complex, a weakly positive signal was obtained. Tuberculosis was suspected and treatment was started with isoniazid, ethambutol and ciprofloxacin. Sequencing of the gene of the 16S rRNA, however, identified the isolates as belonging to a new, slow-growing atypical mycobacterial species, Mycobacterium celatum (M. celatum). Treatment was modified to take into account the previously described primary resistance of M. celatum to antituberculous drugs, whereupon the patient improved.
一名29岁的艾滋病患者因体重减轻、发热和咳嗽入院。痰液、血液和支气管肺泡灌洗的分枝杆菌培养物在培养3周后呈阳性。使用DNA探针鉴定结核分枝杆菌复合群时,获得了弱阳性信号。怀疑为结核病,开始使用异烟肼、乙胺丁醇和环丙沙星进行治疗。然而,16S rRNA基因测序确定分离株属于一种新的、生长缓慢的非典型分枝杆菌物种,即塞拉托分枝杆菌(M. celatum)。考虑到先前描述的塞拉托分枝杆菌对抗结核药物的原发性耐药性,调整了治疗方案,患者随后病情好转。